Myeloid cell expression of CD200R is modulated in active TB disease and regulates Mycobacterium tuberculosis infection in a biomimetic model

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Myeloid cell expression of CD200R is modulated in active TB disease and regulates Mycobacterium tuberculosis infection in a biomimetic model. / Ahmed, Mohamed; Tezera, Liku B.; Herbert, Nicholas; Chambers, Mark; Reichmann, Michaela T.; Nargan, Kievershen; Kloverpris, Henrik; Karim, Farina; Hlatshwayo, Mbali; Madensein, Rajhmun; Habesh, Munir; Hoque, Monjural; Steyn, Adrie J.C.; Elkington, Paul T.; Leslie, Alasdair J.

I: Frontiers in Immunology, Bind 15, 1360412, 2024.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Ahmed, M, Tezera, LB, Herbert, N, Chambers, M, Reichmann, MT, Nargan, K, Kloverpris, H, Karim, F, Hlatshwayo, M, Madensein, R, Habesh, M, Hoque, M, Steyn, AJC, Elkington, PT & Leslie, AJ 2024, 'Myeloid cell expression of CD200R is modulated in active TB disease and regulates Mycobacterium tuberculosis infection in a biomimetic model', Frontiers in Immunology, bind 15, 1360412. https://doi.org/10.3389/fimmu.2024.1360412

APA

Ahmed, M., Tezera, L. B., Herbert, N., Chambers, M., Reichmann, M. T., Nargan, K., Kloverpris, H., Karim, F., Hlatshwayo, M., Madensein, R., Habesh, M., Hoque, M., Steyn, A. J. C., Elkington, P. T., & Leslie, A. J. (2024). Myeloid cell expression of CD200R is modulated in active TB disease and regulates Mycobacterium tuberculosis infection in a biomimetic model. Frontiers in Immunology, 15, [1360412]. https://doi.org/10.3389/fimmu.2024.1360412

Vancouver

Ahmed M, Tezera LB, Herbert N, Chambers M, Reichmann MT, Nargan K o.a. Myeloid cell expression of CD200R is modulated in active TB disease and regulates Mycobacterium tuberculosis infection in a biomimetic model. Frontiers in Immunology. 2024;15. 1360412. https://doi.org/10.3389/fimmu.2024.1360412

Author

Ahmed, Mohamed ; Tezera, Liku B. ; Herbert, Nicholas ; Chambers, Mark ; Reichmann, Michaela T. ; Nargan, Kievershen ; Kloverpris, Henrik ; Karim, Farina ; Hlatshwayo, Mbali ; Madensein, Rajhmun ; Habesh, Munir ; Hoque, Monjural ; Steyn, Adrie J.C. ; Elkington, Paul T. ; Leslie, Alasdair J. / Myeloid cell expression of CD200R is modulated in active TB disease and regulates Mycobacterium tuberculosis infection in a biomimetic model. I: Frontiers in Immunology. 2024 ; Bind 15.

Bibtex

@article{9c33885ff48b4800b278ff0396be4d65,
title = "Myeloid cell expression of CD200R is modulated in active TB disease and regulates Mycobacterium tuberculosis infection in a biomimetic model",
abstract = "A robust immune response is required for resistance to pulmonary tuberculosis (TB), the primary disease caused by Mycobacterium tuberculosis (Mtb). However, pharmaceutical inhibition of T cell immune checkpoint molecules can result in the rapid development of active disease in latently infected individuals, indicating the importance of T cell immune regulation. In this study, we investigated the potential role of CD200R during Mtb infection, a key immune checkpoint for myeloid cells. Expression of CD200R was consistently downregulated on CD14+ monocytes in the blood of subjects with active TB compared to healthy controls, suggesting potential modulation of this important anti-inflammatory pathway. In homogenized TB-diseased lung tissue, CD200R expression was highly variable on monocytes and CD11b+HLA-DR+ macrophages but tended to be lowest in the most diseased lung tissue sections. This observation was confirmed by fluorescent microscopy, which showed the expression of CD200R on CD68+ macrophages surrounding TB lung granuloma and found expression levels tended to be lower in macrophages closest to the granuloma core and inversely correlated with lesion size. Antibody blockade of CD200R in a biomimetic 3D granuloma-like tissue culture system led to significantly increased Mtb growth. In addition, Mtb infection in this system reduced gene expression of CD200R. These findings indicate that regulation of myeloid cells via CD200R is likely to play an important part in the immune response to TB and may represent a potential target for novel therapeutic intervention.",
keywords = "CD200 receptor, immune checkpoint, innate immunity, pulmonary infection, tuberculosis",
author = "Mohamed Ahmed and Tezera, {Liku B.} and Nicholas Herbert and Mark Chambers and Reichmann, {Michaela T.} and Kievershen Nargan and Henrik Kloverpris and Farina Karim and Mbali Hlatshwayo and Rajhmun Madensein and Munir Habesh and Monjural Hoque and Steyn, {Adrie J.C.} and Elkington, {Paul T.} and Leslie, {Alasdair J.}",
note = "Publisher Copyright: Copyright {\textcopyright} 2024 Ahmed, Tezera, Herbert, Chambers, Reichmann, Nargan, Kloverpris, Karim, Hlatshwayo, Madensein, Habesh, Hoque, Steyn, Elkington and Leslie.",
year = "2024",
doi = "10.3389/fimmu.2024.1360412",
language = "English",
volume = "15",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Research Foundation",

}

RIS

TY - JOUR

T1 - Myeloid cell expression of CD200R is modulated in active TB disease and regulates Mycobacterium tuberculosis infection in a biomimetic model

AU - Ahmed, Mohamed

AU - Tezera, Liku B.

AU - Herbert, Nicholas

AU - Chambers, Mark

AU - Reichmann, Michaela T.

AU - Nargan, Kievershen

AU - Kloverpris, Henrik

AU - Karim, Farina

AU - Hlatshwayo, Mbali

AU - Madensein, Rajhmun

AU - Habesh, Munir

AU - Hoque, Monjural

AU - Steyn, Adrie J.C.

AU - Elkington, Paul T.

AU - Leslie, Alasdair J.

N1 - Publisher Copyright: Copyright © 2024 Ahmed, Tezera, Herbert, Chambers, Reichmann, Nargan, Kloverpris, Karim, Hlatshwayo, Madensein, Habesh, Hoque, Steyn, Elkington and Leslie.

PY - 2024

Y1 - 2024

N2 - A robust immune response is required for resistance to pulmonary tuberculosis (TB), the primary disease caused by Mycobacterium tuberculosis (Mtb). However, pharmaceutical inhibition of T cell immune checkpoint molecules can result in the rapid development of active disease in latently infected individuals, indicating the importance of T cell immune regulation. In this study, we investigated the potential role of CD200R during Mtb infection, a key immune checkpoint for myeloid cells. Expression of CD200R was consistently downregulated on CD14+ monocytes in the blood of subjects with active TB compared to healthy controls, suggesting potential modulation of this important anti-inflammatory pathway. In homogenized TB-diseased lung tissue, CD200R expression was highly variable on monocytes and CD11b+HLA-DR+ macrophages but tended to be lowest in the most diseased lung tissue sections. This observation was confirmed by fluorescent microscopy, which showed the expression of CD200R on CD68+ macrophages surrounding TB lung granuloma and found expression levels tended to be lower in macrophages closest to the granuloma core and inversely correlated with lesion size. Antibody blockade of CD200R in a biomimetic 3D granuloma-like tissue culture system led to significantly increased Mtb growth. In addition, Mtb infection in this system reduced gene expression of CD200R. These findings indicate that regulation of myeloid cells via CD200R is likely to play an important part in the immune response to TB and may represent a potential target for novel therapeutic intervention.

AB - A robust immune response is required for resistance to pulmonary tuberculosis (TB), the primary disease caused by Mycobacterium tuberculosis (Mtb). However, pharmaceutical inhibition of T cell immune checkpoint molecules can result in the rapid development of active disease in latently infected individuals, indicating the importance of T cell immune regulation. In this study, we investigated the potential role of CD200R during Mtb infection, a key immune checkpoint for myeloid cells. Expression of CD200R was consistently downregulated on CD14+ monocytes in the blood of subjects with active TB compared to healthy controls, suggesting potential modulation of this important anti-inflammatory pathway. In homogenized TB-diseased lung tissue, CD200R expression was highly variable on monocytes and CD11b+HLA-DR+ macrophages but tended to be lowest in the most diseased lung tissue sections. This observation was confirmed by fluorescent microscopy, which showed the expression of CD200R on CD68+ macrophages surrounding TB lung granuloma and found expression levels tended to be lower in macrophages closest to the granuloma core and inversely correlated with lesion size. Antibody blockade of CD200R in a biomimetic 3D granuloma-like tissue culture system led to significantly increased Mtb growth. In addition, Mtb infection in this system reduced gene expression of CD200R. These findings indicate that regulation of myeloid cells via CD200R is likely to play an important part in the immune response to TB and may represent a potential target for novel therapeutic intervention.

KW - CD200 receptor

KW - immune checkpoint

KW - innate immunity

KW - pulmonary infection

KW - tuberculosis

U2 - 10.3389/fimmu.2024.1360412

DO - 10.3389/fimmu.2024.1360412

M3 - Journal article

C2 - 38745652

AN - SCOPUS:85192913212

VL - 15

JO - Frontiers in Immunology

JF - Frontiers in Immunology

SN - 1664-3224

M1 - 1360412

ER -

ID: 392580331